GlassScriptPhysician profile
Paul Di Pasquale
NPI 1073559936
$9,645.84
in general payments reported to CMS, 2019-2025
31 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 85% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $794 · 2021: $747 · 2022: $3,627 · 2023: $1,119 · 2024: $810 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.41 |
| Education | $302.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $2,271.72 | 2022 | |
| Merz North America, INC. | $2,032.90 | 2019-2025 | Xeomin |
| Regeneron Healthcare Solutions, INC. | $897.35 | 2021-2025 | Dupixent |
| Medtronic USA, INC. | $708.80 | 2019-2020 | |
| Genzyme Corporation | $673.55 | 2019-2025 | |
| Medtronic, INC. | $436.25 | 2021-2025 | Nim Vital, Propel, Nuvent |
| Stryker Corporation | $350.63 | 2019-2024 | Fiagon Navigation Unit |
| Intersect Ent, INC. | $338.72 | 2019-2022 | |
| Kaleo, INC. | $295.82 | 2019-2023 | Auvi-Q |
| Glaxosmithkline, LLC. | $260.66 | 2021-2025 | Nucala, Trelegy Ellipta |
| Pfizer INC. | $169.86 | 2019-2023 | |
| Inspire Medical Systems, INC. | $147.85 | 2025 | Inspire |
| Smith+Nephew, INC. | $126.52 | 2025 | Tula |
| Hologic Sales and Service, LLC | $105.48 | 2023 | Coolseal Generator |
| Phadia US INC. | $96.54 | 2019-2025 | Immunocap |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $86.31 | 2019-2022 | |
| Optinose US, INC. | $81.53 | 2020-2025 | |
| Amgen INC. | $76.90 | 2025 | Tezspire |
| Genentech USA, INC. | $75.58 | 2021-2025 | Xolair |
| Integra Lifesciences Corporation | $57.87 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Sanofi-Aventis U.S. LLC | $54.95 | 2023 | |
| Abbott Laboratories | $49.61 | 2024 | I-Stat |
| Ars Pharmaceuticals Operations, INC. | $45.26 | 2025 | Neffy |
| Alk-Abello, INC | $41.65 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $39.70 | 2023 | Ryaltris |
| Itamar Medical INC | $31.89 | 2025 | Watchpatone |
| Neurent Medical Limited | $25.71 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Vertical Pharmaceuticals, LLC | $17.77 | 2024 | Dsuvia |
| Apria Healthcare LLC | $17.02 | 2021 | |
| Allergan, INC. | $16.25 | 2021 | |
| Acclarent, INC | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Di Pasquale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.